SCHEMBL16783092

SCHEMBL16783092

CCOc1cc(OC)c(-c2cc(C(=O)Nc3c(F)cncc3F)nn2C)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ STIM1 Q13586 2/20 0.37
▸ ORAI1 Q96D31 2/20 0.37
▸ PDE4D Q08499 4/20 0.36
▸ PDE4A P27815 2/20 0.36
▸ PDE4B Q07343 2/20 0.36
▸ PDE4C Q08493 2/20 0.36
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ CFTR P13569 1/20 0.34
▸ MAPT P10636 4/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ CYP2B6 P20813 1/20 0.34
▸ KCNQ3 O43525 1/20 0.33
▸ KCNQ2 O43526 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16783019 0.94 NPC1 (0.40) NPC1RAB9ASMN1; SMN2KDM4ESTIM1
SCHEMBL16783055 0.92 STIM1 (0.39) NPC1RAB9ASMN1; SMN2KDM4ESTIM1
SCHEMBL16782970 0.92 PDE4D (0.46) NPC1RAB9ASMN1; SMN2KDM4EPDE4D
SCHEMBL16783061 0.89 RAB9A (0.43) NPC1RAB9ASMN1; SMN2KDM4ESTIM1
SCHEMBL16782981 0.88 STIM1 (0.37) NPC1RAB9ASMN1; SMN2STIM1ORAI1
SCHEMBL16782983 0.86 STIM1 (0.39) NPC1RAB9ASMN1; SMN2KDM4ESTIM1
SCHEMBL16782993 0.86 NPC1 (0.46) NPC1RAB9ASMN1; SMN2KDM4EPDE4D
SCHEMBL16783095 0.85 RAB9A (0.42) NPC1RAB9ASMN1; SMN2KDM4ESTIM1
SCHEMBL16783018 0.84 NPC1 (0.44) NPC1RAB9ASMN1; SMN2KDM4EPDE4D
SCHEMBL16783082 0.83 PDE4D (0.46) NPC1RAB9ASMN1; SMN2ORAI1PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES Grünenthal GmbH (DE) 2015-06-18 — — US claimed
WO-2015090579-A1 PYRAZOLYL-BASED CARBOXAMIDES IV Grünenthal GmbH (DE) 2015-06-25 — — WO disclosed
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES Grünenthal GmbH (DE) 2015-06-18 — — US disclosed
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES Grünenthal GmbH (DE) 2015-06-18 — — US disclosed
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES Grünenthal GmbH (DE) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES AADAC, NLRP3, NOD2 NPC1 599/4885RAB9A 3615/4885SMN1; SMN2 2629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback